Viridian Therapeutics, Inc.
NASDAQ:VRDN
21.06 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 102.827 | 155.579 | 42.299 | 45.897 | 24.846 | 32.606 | 47.441 | 3.341 | 10.832 | 5.119 | 0.209 | 0.113 |
| Short Term Investments
| 374.543 | 268.971 | 154.666 | 81.742 | 1.999 | 29.875 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 477.37 | 424.55 | 196.965 | 127.639 | 26.845 | 62.481 | 47.441 | 3.341 | 10.832 | 5.119 | 0.209 | 0.113 |
| Net Receivables
| 0.102 | 0.102 | 0.451 | 0 | 0.108 | 0.024 | 1.456 | 0.524 | 0.394 | 1.088 | 0.994 | 1.196 |
| Inventory
| 0 | -6.623 | 0 | 0 | 0 | 0 | 0 | 0.064 | 0.187 | 0.179 | 0.357 | 0.17 |
| Other Current Assets
| 9.006 | 6.521 | 2.747 | 1.972 | 2.786 | 2.865 | 2.971 | 0.16 | 0.321 | 0.349 | 0.444 | 0.13 |
| Total Current Assets
| 486.478 | 424.55 | 200.163 | 129.611 | 29.739 | 65.37 | 51.868 | 4.259 | 11.734 | 6.785 | 2.055 | 1.664 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 3.342 | 2.936 | 2.055 | 0.787 | 0.523 | 0.727 | 0.563 | 0.625 | 1.153 | 1.214 | 0.928 | 1.072 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.604 | 7.605 | 1.491 | 0.857 | -0.523 | 0.05 | 0.05 | 0.258 | 0.015 | 0.09 | 0.69 | 0.046 |
| Total Non-Current Assets
| 3.946 | 10.541 | 3.546 | 1.644 | 0.523 | 0.777 | 0.613 | 0.883 | 1.168 | 1.304 | 1.618 | 1.117 |
| Total Assets
| 490.424 | 435.091 | 203.709 | 131.255 | 30.262 | 66.147 | 52.481 | 4.259 | 12.902 | 8.089 | 3.673 | 2.781 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 2.239 | 14.234 | 2.329 | 0.67 | 1.096 | 0.571 | 0.906 | 0.159 | 0.242 | 0.255 | 0.41 | 0.027 |
| Short Term Debt
| 0.843 | 0.613 | 0.52 | 0.455 | 3.976 | 2.294 | 0 | 1.045 | 1.105 | 0.08 | 0.697 | 22.587 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.076 | 0 |
| Deferred Revenue
| 0.288 | 0.288 | 0.289 | 0.301 | 5.008 | 3.786 | 0 | 3.377 | 1.018 | 0 | 0.076 | 0.788 |
| Other Current Liabilities
| 23.265 | 18.214 | 10.498 | 9.248 | 0.1 | 0.082 | 2.991 | 0.004 | 0.103 | 1.654 | 0.203 | 0.2 |
| Total Current Liabilities
| 26.635 | 33.349 | 13.636 | 10.674 | 10.18 | 6.733 | 3.897 | 4.585 | 2.468 | 1.989 | 1.387 | 23.602 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 20.205 | 4.645 | 0 | 0 | 4.328 | 8.004 | 9.922 | 2.82 | 4.665 | 0 | 0 | 0.042 |
| Deferred Revenue Non-Current
| 0.573 | 0.861 | 1.149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.989 | 1.172 | 1.208 | 0.544 | -4.328 | 0.066 | 0.152 | 0 | -4.641 | 0.109 | 0.259 | 0.579 |
| Total Non-Current Liabilities
| 21.767 | 6.678 | 2.357 | 0.544 | 4.328 | 8.07 | 10.074 | 2.82 | 0.024 | 0.109 | 0.259 | 0.621 |
| Total Liabilities
| 48.402 | 40.027 | 15.993 | 11.218 | 14.508 | 14.803 | 13.971 | 4.585 | 2.492 | 2.098 | 1.646 | 24.223 |
| Equity: | ||||||||||||
| Preferred Stock
| 206.516 | 142.147 | 133.833 | 180.801 | 0 | 0 | 52.481 | 76.976 | 60.85 | 36.057 | 0 | 0 |
| Common Stock
| 0.54 | 0.414 | 0.239 | 0.042 | 0.349 | 0.308 | 0.226 | 0.007 | 0.106 | 0.038 | 0.028 | 0 |
| Retained Earnings
| -725.908 | -488.174 | -358.3 | -278.887 | -168.169 | -126.296 | -93.593 | -30.642 | -17.968 | -6.64 | -25.887 | -21.442 |
| Accumulated Other Comprehensive Income/Loss
| 0.338 | -0.39 | -0.157 | -0.008 | 0 | -0.003 | -2.835 | -0 | -0.739 | -0.555 | -0.411 | -0.263 |
| Other Total Stockholders Equity
| 960.536 | 741.067 | 412.101 | 218.089 | 183.574 | 177.335 | 82.231 | -46.667 | -31.839 | -22.909 | 28.297 | 0.263 |
| Total Shareholders Equity
| 442.022 | 395.064 | 187.716 | 120.037 | 15.754 | 51.344 | 38.51 | -0.326 | 10.41 | 5.991 | 2.027 | -21.442 |
| Total Equity
| 442.022 | 395.064 | 187.716 | 120.037 | 15.754 | 51.344 | 38.51 | -0.326 | 10.41 | 5.991 | 2.027 | -21.442 |
| Total Liabilities & Shareholders Equity
| 490.424 | 435.091 | 203.709 | 131.255 | 30.262 | 66.147 | 52.481 | 4.259 | 12.902 | 8.089 | 3.673 | 2.781 |